Sheng-Xian Yuan (Shengxian Yuan)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Prognostic Factors

Sentinel Lymph Node

Top Venues

British journal of cancer

Cancer discovery

Hepatology communications

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu, Yuan Yang, Xiao-Jie Gan, Sheng-Xian Yuan, Wei-Ping Zhou
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology communications 8 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical activation of oncogenic signaling as a cancer treatment strategy. Cancer discovery (2024)
Matheus Henrique Dias, Anoek Friskes, Siying Wang, João M Fernandes Neto, Frank van Gemert, Soufiane M C Mourragui, Chrysa Papagianni, Hendrik J Kuiken, Sara Mainardi, Daniel Alvarez-Villanueva, Cor Lieftink, Ben Morris, Anna Dekker, Emma van Dijk, Lieke H S Wilms, Marcelo Santos da Silva, Robin A Jansen, Antonio Mulero-Sanchez, Elke Malzer, August Vidal Bel, Cristina Santos, Ramón Salazar, Rosangela A M Wailemann, Thompson E P Torres, Giulia De Conti, Jonne A Raaijmakers, Petur Snaebjornsson, Sheng-Xian Yuan, Wenxin Qin, John S Kovach, Hugo Aguirre Armelin, Hein Te Riele, Alexander van Oudernaarden, Haojie Jin, Roderick L Beijersbergen, Alberto Villanueva, René H Medema, René Bernards
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy. Cancer discovery 14 (7) (2024)
Dapeng Sun, Xiaojie Gan, Lei Liu, Yuan Yang, Dongyang Ding, Wen Li, Junyao Jiang, Wenbin Ding, Linghao Zhao, Guojun Hou, Jian Yu, Jie Wang, Fu Yang, Sheng-Xian Yuan, Wei-Ping Zhou
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell death & disease 13 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)
Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, Guo-Jun Hou, Qi-Fei Tao, Da-Peng Sun, Wen Li, Yuan Yang, Wen-Bin Ding, Jian Yu, Lei Liu, Fu Yang, Wei-Ping Zhou, Sheng-Xian Yuan
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma. British journal of cancer 128 (5) (2022)